Amyotrophic lateral sclerosis is a complex, terminal condition that progressively destroys voluntary muscle control.
In short: Often called Lou Gehrig's disease, this neurodegenerative disorder causes the gradual loss of motor neurons, leading to muscle weakness, stiffness, and eventual respiratory failure. While most cases appear sporadically without a known cause, the disease remains a profound medical challenge with no cure and a typically short survival window.
Amyotrophic lateral sclerosis (ALS) is a progressive condition characterized by the degeneration of motor neurons, the cells responsible for voluntary muscle movement. The disease manifests in two primary forms: limb-onset, which typically begins with weakness in the arms or legs, and bulbar-onset, which starts with difficulties in speech or swallowing. As the disease advances, patients often experience muscle wasting, cramping, and fasciculations. While sensory and autonomic functions generally remain intact, the loss of motor control eventually impacts the ability to breathe, eat, and move independently.
The vast majority of cases, roughly 90 to 95 percent, are classified as sporadic, meaning they occur without a clear family history. The remaining 5 to 10 percent are familial, often linked to specific genetic mutations such as those in the C9orf72 gene. Researchers currently favor a multi-step liability model, suggesting that the disease arises from an interaction between an individual's genetic predisposition and their cumulative lifetime exposure to environmental factors like heavy metals, pesticides, or physical trauma. Despite extensive study, no single environmental trigger has been definitively proven to cause the condition.
Diagnosis is primarily based on clinical signs and symptoms, often supported by the ALS Functional Rating Scale-Revised (ALSFRS-R) to measure progression. While treatments like riluzole and edaravone can slow the disease's advancement, there is no cure. Most patients survive between two and four years following diagnosis, with respiratory failure being the most common cause of death. Although the prognosis is generally poor, the disease spectrum is broad, and a small percentage of individuals survive for more than a decade, highlighting the significant variability in how the condition presents and progresses across different patients.
The disease is also increasingly understood as part of a shared spectrum with frontotemporal dementia, as cognitive and behavioral changes occur in up to 50 percent of patients. This intersection of neurological, genetic, and environmental factors makes ALS a uniquely complex disorder, where the site of onset and age at diagnosis significantly influence the clinical trajectory and the burden of care for both patients and their families.
Opens the Intellect+ feed with this card first. Swipe up for the next one.
Sources
- Summary by Intellect · source: ALS
- Also: Wikidata — amyotrophic lateral sclerosis · CC0
- Also: Wikidata — Als · CC0
To cite this card, link to https://intellectplus.co.uk/app/sport-als.
How we source, check and correct cards: Editorial standards.
General information, not professional advice. Spotted an error? Flag the card or see corrections and complaints.
Intellect Plus is a visual educational discovery platform for exploring fascinating facts and ideas. Brain Food, Not Brain Rot. What is Intellect Plus?
Related
More in Medicine · More in Health · Latest · A–Z · All topics